Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2022-09-22 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
首次公开发行股票并在创业板上市投资风险特别公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票并在创业板上市投资风险特别公告" which translates to "Initial Public Offering (IPO) and Listing on the Growth Enterprise Market - Special Investment Risk Announcement." It discusses the IPO pricing, underwriting, regulatory approvals, risk factors, and subscription details. It references the China Securities Regulatory Commission (CSRC) registration and Shenzhen Stock Exchange rules. The document is a detailed announcement about the IPO process, pricing, risk disclosures, and subscription instructions, but it is not a financial report like an Annual Report or Interim Report. It is not a simple announcement of a report publication but a substantive disclosure related to capital raising and stock issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (9673 characters) and content confirm it is a full disclosure rather than a brief announcement or certification. Hence, the classification is CAP with high confidence.
2022-09-22 Chinese
首次公开发行股票并在创业板上市新股发行公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd., including information about the stock issuance, pricing, underwriting, subscription process, investor instructions, and regulatory compliance. It references regulatory bodies such as the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange, and includes detailed pricing, subscription dates, and risk disclosures. The document is not a financial report like an annual or quarterly report, nor is it a transcript, audit report, or management change announcement. It is a formal announcement related to the capital raising activity of the company through an IPO. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement of a report publication (RPA) or a regulatory filing (RNS).
2022-09-22 Chinese
东兴证券股份有限公司关于公司首次公开发行股票并在创业板上市战略投资者专项核查报告
Regulatory Filings Classification · 95% confidence The document is titled as a "专项核查报告" (Special Inspection Report) issued by Dongxing Securities Co., Ltd. regarding the strategic investors involved in the initial public offering (IPO) and listing of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. on the ChiNext board. It details the approval process, strategic investor selection, subscription amounts, compliance, and legal opinions related to the IPO. The content focuses on the verification and compliance of strategic investors for the IPO, not on the IPO announcement itself or the full financial report. It is a specialized report related to the IPO process, specifically a verification report by the sponsor and underwriter. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance document that does not fit into other categories like Annual Report, Capital/Financing Update, or Earnings Release. The document is substantive and detailed but does not contain financial statements or earnings data, nor is it a proxy or voting result announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-09-22 Chinese
北京市天元律师事务所关于公司首次公开发行股票并在创业板上市战略投资者核查事项的专项法律意见
Regulatory Filings
2022-09-22 Chinese
首次公开发行股票并在创业板上市网上路演公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd., including details about the stock issuance, strategic placement, pricing, and the upcoming online roadshow for investors. It mentions the approval by the China Securities Regulatory Commission and the Shenzhen Stock Exchange, and provides information about the roadshow date and participation. The document does not contain actual financial statements or detailed financial analysis but serves as a notice to investors about the IPO process and the roadshow event. Given the content and length (2140 characters), it is an announcement related to capital raising activities and investor communication rather than a full financial report or detailed presentation. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-09-21 Chinese
股东大会有关本次发行并上市的决议
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2021 Second Extraordinary General Meeting Resolution" of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It details the resolutions passed at a shareholders' meeting, including approval of a proposal for the company's initial public offering (IPO) of A shares and listing on the Shenzhen Stock Exchange. The document contains voting results for various proposals related to the IPO, fundraising projects, dividend distribution plans, and authorization for the board to handle IPO-related matters. The content is focused on the official voting results and decisions made at the shareholders' meeting rather than the full report or financial statements. The document length is 4186 characters, which is relatively short and consistent with a formal announcement of voting results rather than a full report. Therefore, this document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2022-09-15 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.